|
Rios SJ, Rivera-Caravaca JM, Aroca-Valverde C, Reguilon-Gallego L, Castillo-Rodriguez M, Esteve-Pastor MA, Vicente V, Marin F, Roldan V. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists. QJM. 2019 Mar 1;112(3):183-188. doi: 10.1093/qjmed/hcy250. PubMed PMID: 30380132.
AÑO: 2019; IF: 2.529
|
30380132
|
Rivera-Caravaca JM, Esteve-Pastor MA, Marín F, Valdés M, Vicente V, Roldán V, Lip GYH. A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials. Mayo Clin Proc. 2018 Aug;93(8):1065-1073. doi: 10.1016/j.mayocp.2018.01.028. Epub 2018 May 2. PubMed PMID: 29730090.
AÑO: 2018; IF: 11.104
|
|
Serna MJ, Rivera-Caravaca JM, Gonzalez-Conejero R, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Roldán V, Marín F. Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. Eur J Clin Invest. 2018 Jun;48(6):e12929. doi: 10.1111/eci.12929. Epub 2018 Apr 17. PubMed PMID: 29577257.
AÑO: 2018; IF: 5.722
|
|
Rivera-Caravaca JM, Roldán V, Romera M, Esteve-Pastor MA, Valdés M, Lip GYH, Vicente V, Marín F. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project. J Gen Intern Med. 2018 Jun;33(6):847-854. doi: 10.1007/s11606-017-4279-4. Epub 2018 Mar 22. PubMed PMID: 29569024; PubMed Central PMCID: PMC5975135.
AÑO: 2018; IF: 6.473
|
|
Pastori D, Rivera-Caravaca JM, Esteve-Pastor MA, Roldán V, Marín F, Pignatelli P, Violi F, Lip GYH. Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients. Circ J. 2018 Apr 25;82(5):1286-1292. doi: 10.1253/circj.CJ-17-1318. Epub 2018 Mar 16. PubMed PMID: 29553090.
AÑO: 2018; IF: 3.025
|